agilon health (AGL) Stock Price, News & Analysis

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 1 sell rating, 12 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGL, but not buy additional shares or sell existing shares.
View AGL analyst ratings or view top-rated stocks.

17 Wall Street analysts have issued 12-month price targets for agilon health's shares. Their AGL share price targets range from $5.00 to $18.00. On average, they anticipate the company's share price to reach $9.32 in the next twelve months. This suggests a possible upside of 93.0% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $12.55 at the beginning of 2024. Since then, AGL stock has decreased by 61.5% and is now trading at $4.83.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our AGL earnings forecast.

agilon health will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

agilon health, inc. (NYSE:AGL) posted its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.13. The company earned $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative trailing twelve-month return on equity of 21.74%. The company's quarterly revenue was up 71.8% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.14) EPS.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include Counterpoint Quantitative Equity ETF (CPAI), SPDR S&P Health Care Services ETF (XHS), Fidelity Disruptive Medicine ETF (FMED), Texas Capital Texas Equity Index ETF (TXS), Renaissance IPO ETF (IPO) and Fidelity Fundamental Large Cap Growth ETF (FGRO).iShares U.S. Healthcare Providers ETF (IHF).

agilon health issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.4 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

agilon health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Checchi Capital Advisers LLC (0.06%), Renaissance Capital LLC (0.05%), Counterpoint Mutual Funds LLC (0.02%), Yarger Wealth Strategies LLC (0.01%), Simplex Trading LLC (0.00%) and Simplicity Wealth LLC (0.00%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.